EDITORIAL
Accepted on 11 Apr 2025
Advanced Therapeutic Strategies and Safety Profiles in Heart Failure with Reduced Ejection Fraction: Contextualizing Recent Findings
doi 10.3389/fphar.2025.1607362
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Research Topics
- Advanced Therapeutic Strategies and Safety Profiles in Heart Failure with Reduced Ejection Fraction
Advanced Therapeutic Strategies and Safety Profiles in Heart Failure with Reduced Ejection Fraction
1,701
Total downloads
6,574
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 04 Mar 2025
Short-term outpatient follow-up of vericiguat treatment in patients hospitalized for heart failure
doi 10.3389/fcvm.2025.1465700
- 505 views
ORIGINAL RESEARCH
Published on 27 Jan 2025
Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
doi 10.3389/fphar.2024.1496380
- 452 views
ORIGINAL RESEARCH
Published on 15 Jan 2025
Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database
doi 10.3389/fphar.2024.1523136
- 954 views
ORIGINAL RESEARCH
Published on 13 Nov 2023
Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study
doi 10.3389/fphar.2023.1291896
- 983 views
ORIGINAL RESEARCH
Published on 09 Jun 2023
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach
doi 10.3389/fphar.2023.1175606
- 1,859 views
- 6 citations
